Doukky Rami, Olusanya Adebayo, Vashistha Raj, Saini Abhimanyu, Fughhi Ibtihaj, Mansour Khaled, Nigatu Abiy, Confer Kara, Sims Shannon A
Division of Cardiology, John H. Stroger, Jr. Hospital of Cook County, 1901 W. Harrison St. Suite 3620, Chicago, IL, 60612, USA,
J Nucl Cardiol. 2015 Aug;22(4):700-13. doi: 10.1007/s12350-014-0047-6. Epub 2015 Apr 24.
The diagnostic and prognostic value of regadenoson-induced ST-segment depression (ST↓) is not defined. Due to the low incidence of ST↓ ≥1.0 mm with vasodilator stress, a lower threshold to define ischemic ECG response may provide improved clinical utility.
We conducted a retrospective cohort study of patients who underwent regadenoson-stress SPECT myocardial perfusion imaging (MPI) followed by coronary angiography within 6 months. Ischemic ST↓ was defined as ≥0.5 mm. The prevalence of angiographically severe coronary artery disease (CAD) and the rates of major adverse cardiac events (MACE) including cardiac death, myocardial infarction, and coronary revascularization were determined.
In a diagnostic cohort of 629 subjects, 117 (18.6%) had ST↓ ≥0.5 mm. Severe CAD was more prevalent in the ST↓ ≥0.5 vs ST <0.5 group (13.7% vs 5.3%, P = .001). Among patients with normal MPI (n = 229), the prevalence of severe CAD was higher in the ST↓ ≥0.5 group (8.2% vs 2.2%, P = .04). Adjusting for clinical and imaging covariates, ST↓ ≥0.5 mm was independently predictive of severe CAD [odds ratio = 3.37, 95% confidence interval (CI) = 1.67-6.83, P = .001], and provided incremental diagnostic value (Chi square increment = 10.3, P = .001). In an outcome cohort of 748 subjects, after adjusting for clinical and imaging covariates, ST↓ ≥0.5 mm was associated with increased MACE rate in the entire cohort [hazard ratio = 1.41, CI 1.01-1.96, P = .04] and in the subgroup of patients with normal MPI [hazard ratio = 2.2, CI 1.11-4.39, P = .02], and provided incremental prognostic value (Chi square increment = 3.9, P = .049). A diagnostic ST↓ threshold of 0.5 mm provided greater discriminatory capacity than a 1.0 mm cutoff (P = .03).
Among patients selected to undergo coronary angiography, regadenoson-induced ST↓ ≥0.5 mm was associated with higher rates of severe CAD and MACE, irrespective of MPI finding.
雷加曲班诱导的ST段压低(ST↓)的诊断和预后价值尚未明确。由于血管扩张剂负荷试验中ST↓≥1.0 mm的发生率较低,采用较低的阈值来定义缺血性心电图反应可能会提高临床实用性。
我们对在6个月内接受雷加曲班负荷单光子发射计算机断层扫描心肌灌注成像(MPI)并随后接受冠状动脉造影的患者进行了一项回顾性队列研究。缺血性ST↓定义为≥0.5 mm。确定造影显示的严重冠状动脉疾病(CAD)的患病率以及包括心源性死亡、心肌梗死和冠状动脉血运重建在内的主要不良心脏事件(MACE)的发生率。
在一个由629名受试者组成的诊断队列中,117名(18.6%)患者ST↓≥0.5 mm。ST↓≥0.5 mm组的严重CAD患病率高于ST<0.5 mm组(13.7%对5.3%,P = .001)。在MPI正常的患者(n = 229)中,ST↓≥0.5 mm组的严重CAD患病率更高(8.2%对2.2%,P = .04)。在调整临床和影像协变量后,ST↓≥0.5 mm是严重CAD的独立预测因素[比值比 = 3.37,95%置信区间(CI)= 1.67 - 6.83,P = .001],并提供了额外的诊断价值(卡方增量 = 10.3,P = .001)。在一个由748名受试者组成的结局队列中,在调整临床和影像协变量后,ST↓≥0.5 mm与整个队列中MACE发生率增加相关[风险比 = 1.41,CI 1.01 - 1.96,P = .04],在MPI正常的患者亚组中也是如此[风险比 = 2.2,CI 1.11 - 4.39,P = .02]并提供了额外的预后价值(卡方增量 = 3.9,P = .049)。0.5 mm的诊断性ST↓阈值比1.0 mm的截断值具有更大的鉴别能力(P = .03)。
在选择进行冠状动脉造影的患者中,无论MPI结果如何,雷加曲班诱导的ST↓≥0.5 mm与严重CAD和MACE的发生率较高相关。